Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fersinsa GB is a leading Mexican pharmaceutical company specializing in the production of beta-lactam active pharmaceutical ingredients (APIs). Based in Ramos Arizpe, Coahuila, the company is one of the world's largest producers of Penicillin G and its essential intermediates, such as 6-APA. It utilizes advanced enzymatic synthesis and large-scale fermentation technologies to manufacture high-quality antibiotics, including amoxicillin and ampicillin. Originally part of Grupo Bioquímico, it was fully acquired by DSM (now Centrient Pharmaceuticals) in 2006. Today, it serves as a critical manufacturing hub within Centrient's global supply chain, providing sustainable and essential medicines to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fersinsa GB.